** Shares of metabolic health solutions firm ReShape Lifesciences RSLS.O fall 57.5% to $1 premarket
** On Saturday, RSLS said it is raising $6 mln through a public offering of shares and warrants
** Co selling ~2.6 mln units, each consisting of one share and one warrant, at $2.33 per unit
** Warrants can be exercised at a price of $5.83 per share, after stockholder approval
** Maxim Group LLC is acting as the sole agent for the offering
** RSLS fell ~71% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。